
Brianna Keilar @brikeilarcnn
In mid-June, the FDA revoked emergency use authorization for the drug because it was “unlikely to be effective in treating COVID-19” and “in light of ongoing serious cardiac adverse events and other potential serious side effects”. https://t.co/DRoIMN4p2R — PolitiTweet.org